SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway

Jie Zhao(University of Kansas Medical Center), Zhuan Li(Hunan Normal University)

Journal of Experimental & Clinical Cancer Research

June 13, 2019

10.1186/s13046-019-1246-4

Cited by 92

Related Papers

Protein arginine methyl transferase 1– and Jumonji C domain‐containing protein 6–dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice

|Hepatology|2017|63

Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression

|Cell Death and Differentiation|2015|60

Discovery of SIRT7 Inhibitor as New Therapeutic Options Against Liver Cancer

|Frontiers in Cell and Developmental Biology|2022|40

Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses

|Scientific Reports|2019|36

Hepatic ROS Mediated Macrophage Activation Is Responsible for Irinotecan Induced Liver Injury

|Cells|2022|20